have important implications for the individual tailoring of therapy in patients with AF. I first prescribed amiodarone about 30 years ago, before it was approved for use in the US. Back then we ...

Amiodarone-induced thyrotoxicosis (AIT) remains a challenging problem, often posing difficulties in diagnosis and therapy. Two types of AIT exist and are classified according to their etiology.

In view of the life-threatening nature of the patient's arrhythmia, amiodarone therapy was continued and thionamide (carbimazole) treatment was commenced. AIT has been classified into two types.

We found that for the two most commonly used statins in the United States, concomitant amiodarone therapy is rarely noted in AE reports affecting major organs. In addition, while the likelihood of ...

may be subtle initially and is the most common cause of death related to amiodarone therapy. It can take months to years to develop and occurs in about 1% to 5% of patients taking 200 mg daily ...

The drug amiodarone, with the trade name Cordarone, helps the heart beat normally again when the rhythm is abnormal, such as ...

The drug amiodarone, with the trade name Cordarone, helps the heart beat normally again when the rhythm is abnormal, such as in atrial fibrillation and tachycardia. The treatment requires regular ...

Significant bluish discoloration of the skin can is seen. Discontinuing amiodarone therapy frequently improves the discoloration. The etiology is not clear.